TissueGene Inc (950160)

Currency in KRW
37,050
-900(-2.37%)
Closed·
950160 Scorecard
Full Analysis
Net income is expected to drop this year
950160 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
36,75038,200
52 wk Range
13,19059,300
Key Statistics
Bid/Ask
37,050.00 / 37,100.00
Prev. Close
37,050
Open
38,000
Day's Range
36,750-38,200
52 wk Range
13,190-59,300
Volume
144.74K
Average Volume (3m)
324.68K
1-Year Change
137.5%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
950160 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
100,000
Upside
+169.91%
Members' Sentiments
Bearish
Bullish
ProTips
Short term obligations exceed liquid assets

TissueGene Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

TissueGene Inc Company Profile

Kolon TissueGene, Inc. develops cell therapies for orthopedic diseases and other unmet medical needs. The company’s lead product is the TG-C that has completed Phase II trials to treat osteoarthritis, as well as rheumatoid arthritis, meniscus, and spinal discs. It is also developing cell therapies for musculoskeletal system disorders, as well as vet medicine. Kolon TissueGene, Inc. was formerly known as TissueGene, Inc. and changed its name to Kolon TissueGene, Inc. in March 2018. The company was founded in 1999 and is headquartered in Rockville, Maryland.

Compare 950160 to Peers and Sector

Metrics to compare
950160
Peers
Sector
Relationship
P/E Ratio
−35.0x−4.4x−0.5x
PEG Ratio
0.10−0.590.00
Price/Book
26.5x3.1x2.6x
Price / LTM Sales
559.9x13.8x3.2x
Upside (Analyst Target)
169.9%62.7%38.8%
Fair Value Upside
Unlock4.1%5.4%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 100,000
(+169.91% Upside)

Earnings

Latest Release
May 15, 2025
EPS / Forecast
-72.60 / --
Revenue / Forecast
1.29B / --
EPS Revisions
Last 90 days

950160 Income Statement

People Also Watch

29,850
009420
-0.83%
167,600
068270
-2.78%
52,200
214150
-0.38%
98,600
326030
-1.00%
47,250
302440
-1.15%

FAQ

What Stock Exchange Does TissueGene Trade On?

TissueGene is listed and trades on the KOSDAQ stock exchange.

What Is the Stock Symbol for TissueGene?

The stock symbol for TissueGene is "950160."

What Is the TissueGene Market Cap?

As of today, TissueGene market cap is 3.08T.

What Is TissueGene's Earnings Per Share (TTM)?

The TissueGene EPS (TTM) is -452.29.

From a Technical Analysis Perspective, Is 950160 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has TissueGene Stock Split?

TissueGene has split 0 times.

How Many Employees Does TissueGene Have?

TissueGene has 0 employees.

What is the current trading status of TissueGene (950160)?

As of 31 Aug 2025, TissueGene (950160) is trading at a price of 37,050, with a previous close of 37,050.00. The stock has fluctuated within a day range of 36,750 to 38,200, while its 52-week range spans from 13,190 to 59,300.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.